Well, well...
NewScientist.com - NEWSFLASH
------------------------------------------------------------------------
Cord blood yields 'ethical' embryonic stem cells
Hopes for treating disease with stem cells from umbilical cord blood
have received a major boost, following the discovery of primitive
cells with clinical potential matching that of embryonic stem cells.
Embryonic stem cells are derived from human fetuses, which are then
destroyed, and have become a major ethical issue, especially in the
US. But umbilical cord blood can be saved, stored and multiplied
without any of these ethical dilemmas.
Furthermore, the same team is applying new microgravity technology -
originally developed by NASA for the International Space Station -
to make large enough quantities of the stem cells to repair tissue
damage in patients.
Click on the link below for the full story on NewScientist.com:
http://www.newscientist.com/article.ns?id=dn7864
Science and technology news and features updated daily at:
http://www.newscientist.com
Subscribe to New Scientist magazine and get 4 FREE ISSUES at:
http://www.qssa.co.uk/new_scientist/default.asp?promcode=2169
-------------------------------------------------------------------------
NewScientist.com's Newsflash emails are an additional free service
to from NewScientist.com e-zines. Newsflash emails come from
NewScientist's online daily news service, and stories are available
exclusively online. The alerts are sent on an occasional basis when
a story of especially high interest breaks.
If you would prefer not to receive Newsflashes from
NewScientist.com, please click on the following link:
http://www.prq0.com/quickstart/LeadCapture/Display_LeadCapture.asp?e=XbcbdeacBD-RaA&oid=UcjjbCB
Please note that replies to this email address will not be read. To
receive a response to your message, please email
[EMAIL PROTECTED]
_______________________________________________
Futurework mailing list
[email protected]
http://fes.uwaterloo.ca/mailman/listinfo/futurework
